Literature DB >> 10932078

IL-5 production by bone marrow stromal cells: implications for eosinophilia associated with asthma.

M B Hogan1, D Piktel, K S Landreth.   

Abstract

BACKGROUND: Eosinophil infiltration of bronchial tissue is a hallmark of asthma. Recruitment of eosinophils into pulmonary tissue is dependent on the presence of IL-5. In addition, IL-5 plays a significant role in the differentiation, proliferation, and maturation of eosinophil progenitor cells in the bone marrow before recruitment into the lung. The contribution of bone marrow eosinophil production to eosinophilia associated with asthma is poorly understood.
OBJECTIVE: The aims of this study were to determine whether bone marrow stromal cells produce IL-5 and to determine whether IL-5 production by stromal cells is upregulated by IL-1, an inflammatory cytokine associated with asthma.
METHODS: IL-5 messenger (m)RNA from bone marrow stromal cells was amplified by RT-PCR and sequenced. Stromal cells were lysed, and IL-5 protein production was measured by ELISA. Upregulation of stromal cell IL-5 transcription, translation, and functional effect on eosinophil differentiation was evaluated after stimulation with recombinant IL-1alpha and IL-1beta and compared with untreated cells.
RESULTS: Bone marrow stromal cells transcribe and translate IL-5. The nucleotide sequence of IL-5 mRNA from stromal cells was identical to that previously reported for murine T cells. IL-5 mRNA abundance in stromal cells increased with increasing cell confluence in culture. IL-5 mRNA and protein levels were upregulated by exposure of stromal cells to the inflammatory cytokines IL-1alpha and IL-1beta. Exposure of stromal cells to IL-1 resulted in increased eosinophil differentiation in coculture experiments with nonadherent bone marrow cells.
CONCLUSION: The production of IL-5 mRNA and protein by bone marrow stromal cells is a novel finding that has implications for both normal eosinophilopoiesis and development of the accelerated eosinophil production associated with asthma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10932078     DOI: 10.1067/mai.2000.108309

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

1.  Relevance of ex vivo blood lymphocyte assay for in vivo lymphocyte function.

Authors:  N W Brattig; C Timmann; R S Abraha; B Lepping; B Müller-Myhsok; R D Horstmann
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

2.  Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma.

Authors:  Libo Zhang; Herman Yeger; Bikul Das; Meredith S Irwin; Sylvain Baruchel
Journal:  Neoplasia       Date:  2007-01       Impact factor: 5.715

Review 3.  Regulation of allergic airways inflammation by cytokines and glucocorticoids.

Authors:  L Cameron; Q Hamid
Journal:  Curr Allergy Asthma Rep       Date:  2001-03       Impact factor: 4.806

4.  Mast Cell-Activated Bone Marrow Mesenchymal Stromal Cells Regulate Proliferation and Lineage Commitment of CD34(+) Progenitor Cells.

Authors:  Zoulfia Allakhverdi; Michael R Comeau; Myriam Armant; Rachana Agrawal; Judith A Woodfolk; Roma Sehmi; Karen J Howie; Gail M Gauvreau; Guy Delespesse
Journal:  Front Immunol       Date:  2013-12-17       Impact factor: 7.561

Review 5.  Reslizumab in the treatment of inadequately controlled asthma in adults and adolescents with elevated blood eosinophils: clinical trial evidence and future prospects.

Authors:  Jorge Máspero
Journal:  Ther Adv Respir Dis       Date:  2017-07-06       Impact factor: 4.031

Review 6.  Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid use.

Authors:  Diego Jose Maselli; Linda Rogers; Jay I Peters
Journal:  Ther Clin Risk Manag       Date:  2018-10-23       Impact factor: 2.423

7.  Embelin Alleviates Severe Airway Inflammation in OVA-LPS-Induced Rat Model of Allergic Asthma.

Authors:  Shazalyana Azman; Mahendran Sekar; Suzana Wahidin; Siew Hua Gan; Jaishree Vaijanathappa; Srinivasa Reddy Bonam; Mallika Alvala; Pei Teng Lum; Vandana Thakur; Jayesh V Beladiya; Anita A Mehta
Journal:  J Asthma Allergy       Date:  2021-12-15

8.  Effects of bone marrow mononuclear cells from healthy or ovalbumin-induced lung inflammation donors on recipient allergic asthma mice.

Authors:  Soraia C Abreu; Mariana A Antunes; Lucas Mendonça; Vivian C Branco; Elga Bandeira de Melo; Priscilla C Olsen; Bruno L Diaz; Daniel J Weiss; Bruno D Paredes; Debora G Xisto; Marcelo M Morales; Patricia R M Rocco
Journal:  Stem Cell Res Ther       Date:  2014-09-09       Impact factor: 6.832

Review 9.  Reslizumab in the management of poorly controlled asthma: the data so far.

Authors:  Diego Jose Maselli; Maria Ines Velez; Linda Rogers
Journal:  J Asthma Allergy       Date:  2016-08-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.